| 000 | 00934 a2200265 4500 | ||
|---|---|---|---|
| 005 | 20250514034213.0 | ||
| 264 | 0 | _c20021217 | |
| 008 | 200212s 0 0 eng d | ||
| 022 | _a1472-4472 | ||
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aMartinez-Castelao, Alberto | |
| 245 | 0 | 0 |
_aConivaptan (Yamanouchi). _h[electronic resource] |
| 260 |
_bCurrent opinion in investigational drugs (London, England : 2000) _cJan 2002 |
||
| 300 |
_a89-95 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Review | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aBenzazepines _xchemistry |
| 650 | 0 | 4 |
_aClinical Trials as Topic _xmethods |
| 650 | 0 | 4 |
_aEdema _xdrug therapy |
| 650 | 0 | 4 |
_aHeart Failure _xdrug therapy |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aHyponatremia _xdrug therapy |
| 650 | 0 | 4 |
_aTechnology, Pharmaceutical _xmethods |
| 773 | 0 |
_tCurrent opinion in investigational drugs (London, England : 2000) _gvol. 3 _gno. 1 _gp. 89-95 |
|
| 999 |
_c11950196 _d11950196 |
||